5-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti
- 20 August 2009
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 361 (8) , 828-829
- https://doi.org/10.1056/nejmc0809485
Abstract
To the Editor: We report 5-year outcomes of 910 adults with human immunodeficiency virus (HIV) infection who consecutively initiated antiretroviral therapy according to guidelines of the World Health Organization (WHO) from 2003 through 2004. All the patients were followed at the Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) clinic in Port au Prince, Haiti, through May 1, 2009.1,2 Combination therapy with zidovudine, lamivudine, and efavirenz was initiated in 428 patients (47%); therapy with zidovudine, lamivudine, and nevirapine in 381 patients (42%); and other regimens in 101 patients (11%). CD4 counts were measured every 6 . . .Keywords
This publication has 3 references indexed in Scilit:
- Update of the drug resistance mutations in HIV-1: 2007.2007
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Antiretroviral Therapy in a Thousand Patients with AIDS in HaitiNew England Journal of Medicine, 2005